查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363118

计算生物学市场规模、份额、趋势分析报告：按服务、用途、最终用途、地区和细分市场预测，2023-2030 年

Computational Biology Market Size, Share & Trends Analysis Report By Service (Database, Infrastructure & Hardware, Software Platform), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

计算生物学市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球计算生物学市场规模将达到132.5亿美元，复合年复合成长率为13.17%。

癌症研究领域研发投入的增加、个体化药物需求的增加以及活性化的药物研发研究预计将有助于市场开拓。此外，生物技术产业的不断进步和人工智慧技术的采用将进一步推动预测期内的市场成长。

遗传分析中先进技术的日益采用正在推动计算生物学市场的成长。例如，2023 年 1 月，Qiagen Digital Insights (QDI) 宣布推出专为超快次世代定序(NGS) 分析而设计的增强型产品。这项创新解决方案只需 25 分钟即可处理整个基因组，云端运算成本为 1 美元。这预计将使研究人员能够有效地分析和解释来自各种定序方法的资料，包括全基因组定序（WGS）、全外显子定序（WES）和大规模面板定序。因此，预计将在预测期内推动市场成长。

此外，根据 Cryptopolitan 于 2023 年 9 月发表的报导，浦项科技大学 (POSTECH) 的科学家们开发了一种机器，可以在临床试验之前估计新药获得核准的可能性，这是一项重大进展.在《EBioMedicine》杂誌上共用了我们透过学习获得的发现。预计这将有助于了解临床试验期间的药物失败率。因此，技术进步的不断进步预计将在预测期内推动市场成长。

然而，生物系统的复杂性和该领域熟练专业人员的缺乏预计将阻碍市场的成长。生物系统非常复杂，准确地对其行为进行建模非常困难，并且需要熟练且训练有素的专家的存在。许多生物过程涉及复杂的网络和相互作用，进一步增加了分析的复杂性，在某些情况下，使得计算预测不太可靠。

计算生物学市场报告亮点

  • 按服务划分，软体和平台领域市场预计将在 2022 年以 39.06% 的份额主导市场，并在预测期内以最快的年复合成长率成长。这是由于药物研发和开发的增加以及对个体化药物的需求增加。
  • 从用途来看，临床试验领域占据市场主导地位，2022年市占率为26.84%。这主要是由于该领域研究和开发活动的增加。
  • 依最终用途，工业领域占最大市场占有率，2022 年将达到 62.10%。这是由于药物研发、标鉴定、虚拟筛选和药物动力学建模等其他用途的研究活动增加。
  • 2022年，由于主要市场参与者和强大的医疗基础设施的存在，北美以48.93%的份额主导市场。预计这些将在预测期内推动该地区的计算生物学市场。

目录

第1章调查方法与范围

第2章执行摘要

第3章变数、趋势、范围

  • 市场体系预测
  • 市场趋势及展望
  • 市场动态
  • 市场抑制因素分析
  • 营商环境分析

第4章按服务分类的业务分析

  • 计算生物学市场：服务变化分析
  • 资料库
  • 基础设施和硬体
  • 软体平台

第5章按用途的业务分析

  • 计算生物学市场：用途变化分析
  • 药物研发与疾病建模
  • 临床前药物开发
  • 临床试验
  • 计算基因组学
  • 计算蛋白质体学
  • 其他的

第6章最终用途的业务分析

  • 计算生物学市场：最终用途变异分析
  • 学术与研究
  • 产业

第7章区域业务分析

  • 区域市场简介
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第8章竞争形势

  • 公司分类
  • 策略规划
  • 2022 年公司市场占有率/地位分析
  • 公司简介/名单
    • DNAnexus, Inc.
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • Schrodinger, Inc.
    • Compugen
    • Aganitha AI Inc.
    • Genedata AG
    • QIAGEN
    • SIMULATIONS PLUS
    • Fios Genomics
Product Code: 978-1-68038-212-9

Computational Biology Market Growth & Trends:

The global computational biology market size is expected to reach a value of USD 13.25 billion by 2030, according to a new report by Grand View Research, Inc.., exhibiting a CAGR of 13.17%. The growing investments in research & development within the fields of cancer research, increasing demand for personalized medicines, and rising drug discovery & development are anticipated to contribute to the growth of the market. Moreover, the increasing advancements in the biotechnology industry and the adoption of artificial intelligence technology will further drive the market growth over the forecast period.

The growing adoption of advanced technology in gene analysis is propelling the growth of the market for computational biology. For instance, in January 2023, Qiagen Digital Insights (QDI) introduced an enhanced product designed for ultra-rapid next-generation sequencing (NGS) analysis. This innovative solution enables the processing of the entire genome within just 25 minutes, for USD 1 in cloud computing expenses. This is anticipated to empower researchers to efficiently analyze and interpret data from various sequencing approaches, including whole genome sequencing (WGS), whole exome sequencing (WES), and large panel sequencing. Hence, it is anticipated to impel market growth over the forecast period.

Furthermore, according to the article published by Cryptopolitan in September 2023, in a major advance development, scientists at Pohang University of Science and Technology (POSTECH) have shared their discoveries in the EBioMedicine journal, that they have used machine learning to estimate the chances of a new drug getting approved even before the clinical trials. This is expected to help in understanding the rate of drug failure at the time of clinical trials. Thus, the rising advancements in technology are anticipated to fuel the growth of the market over the forecast period.

However, the complexity of the biological systems and the lack of skilled professionals in the field are anticipated to hinder the growth of the market. Biological systems are incredibly complex, and accurately modeling their behavior can be challenging and requires the presence of skilled and trained professionals. Many biological processes involve complicated networks and interactions, which further add to the complexity of analysis and make computational predictions less reliable in some cases.

Computational Biology Market Report Highlights:

  • Based on service, the software & platform segment dominated the market with a share of 39.06% in 2022, and the same is anticipated to grow at the fastest CAGR over the forecast period. This can be attributed to the rising drug discovery & development and growing demand for personalized medicines
  • Based on application, the clinical trials segment dominated the market with a share of 26.84% in 2022. This was primarily due to an increase in the number of R&D initiatives in this field.
  • Based on end-use, the industrial segment held the largest market share of 62.10% in 2022. This can be attributed to the increasing research activities for drug discovery, target identification, virtual screening, and pharmacokinetic modeling, among other applications
  • In 2022, North America dominated the market with a share of 48.93%, owing to the presence of major market players, and robust healthcare infrastructure. These are anticipated to boost the market for computational biology in the region over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Service Segment
    • 1.2.2. Application Segment
    • 1.2.3. End-use Segment
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2
    • 1.9.3. Objective 3

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Growing Adoption Of Bioinformatics Technology
    • 3.3.2. Advancements In Genomic Research
    • 3.3.3. Increasing Demand For Personalized Medicines
  • 3.4. Market Restraint Analysis
    • 3.4.1. Lack of Skilled Professional
    • 3.4.2. Data Privacy And Security Concerns
  • 3.5. Business Environment Analysis
    • 3.5.1. PESTEL Analysis
    • 3.5.2. Porter's Five Forces Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Service Business Analysis

  • 4.1. Computational Biology Market: Service Movement Analysis
  • 4.2. Databases
    • 4.2.1. Databases Market, 2018 - 2030 (USD Million)
  • 4.3. Infrastructure & Hardware
    • 4.3.1. Infrastructure & Hardware, 2018 - 2030 (USD Million)
  • 4.4. Software Platform
    • 4.4.1. Software Platform Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Computational Biology Market: Application Movement Analysis
  • 5.2. Drug Discovery & Disease Modelling
    • 5.2.1. Drug Discovery & Disease Modelling Market, 2018 - 2030 (USD Million)
    • 5.2.2. Target Identification
      • 5.2.2.1. Target Identification Market, 2018 - 2030 (USD Million)
    • 5.2.3. Target Validation
      • 5.2.3.1. Target Validation Market, 2018 - 2030 (USD Million)
    • 5.2.4. Lead Discovery
      • 5.2.4.1. Lead Discovery Market, 2018 - 2030 (USD Million)
    • 5.2.5. Lead Optimization
      • 5.2.5.1. Lead Optimization Market, 2018 - 2030 (USD Million)
  • 5.3. Preclinical Drug Development
    • 5.3.1. Preclinical Drug Development Market, 2018 - 2030 (USD Million)
    • 5.3.2. Pharmacokinetics
      • 5.3.2.1. Pharmacokinetics Market, 2018 - 2030 (USD Million)
    • 5.3.3. Pharmacodynamics
      • 5.3.3.1. Pharmacodynamics Market, 2018 - 2030 (USD Million)
  • 5.4. Clinical Trials
    • 5.4.1. Clinical Trials Market, 2018 - 2030 (USD Million)
    • 5.4.2. Phase I
      • 5.4.2.1. Phase I Market, 2018 - 2030 (USD Million)
    • 5.4.3. Phase II
      • 5.4.3.1. Phase II Market, 2018 - 2030 (USD Million)
    • 5.4.4. Phase III
      • 5.4.4.1. Phase III Market, 2018 - 2030 (USD Million)
    • 5.4.5. Phase IV
      • 5.4.5.1. Phase IV Market, 2018 - 2030 (USD Million)
  • 5.5. Computational Genomics
    • 5.5.1. Computational Genomics Market, 2018 - 2030 (USD Million)
  • 5.6. Computational Proteomics
    • 5.6.1. Computational Proteomics Market, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Computational Biology Market: End-use Movement Analysis
  • 6.2. Academic & Research
    • 6.2.1. Academic & Research Market, 2018 - 2030 (USD Million)
  • 6.3. Industrial
    • 6.3.1. Industrial Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America Computational Biology Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.2.2.2. Key Country Dynamics
      • 7.2.2.3. Competitive Scenario
    • 7.2.3. Canada
      • 7.2.3.1. Canada Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.2.3.2. Key Country Dynamics
      • 7.2.3.3. Competitive Scenario
  • 7.3. Europe
    • 7.3.1. Europe Computational Biology Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.2.2. Key Country Dynamics
      • 7.3.2.3. Competitive Scenario
    • 7.3.3. Germany
      • 7.3.3.1. Germany Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.3.2. Key Country Dynamics
      • 7.3.3.3. Competitive Scenario
    • 7.3.4. Spain
      • 7.3.4.1. Spain Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.4.2. Key Country Dynamics
      • 7.3.4.3. Competitive Scenario
    • 7.3.5. France
      • 7.3.5.1. France Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.5.2. Key Country Dynamics
      • 7.3.5.3. Competitive Scenario
    • 7.3.6. Italy
      • 7.3.6.1. Italy Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.6.2. Key Country Dynamics
      • 7.3.6.3. Competitive Scenario
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.7.2. Key Country Dynamics
      • 7.3.7.3. Competitive Scenario
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.8.2. Key Country Dynamics
      • 7.3.8.3. Competitive Scenario
    • 7.3.9. Norway
      • 7.3.9.1. Norway Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.9.2. Key Country Dynamics
      • 7.3.9.3. Competitive Scenario
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific Computational Biology Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.4.2.2. Key Country Dynamics
      • 7.4.2.3. Competitive Scenario
    • 7.4.3. China
      • 7.4.3.1. China Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.4.3.2. Key Country Dynamics
      • 7.4.3.3. Competitive Scenario
    • 7.4.4. India
      • 7.4.4.1. India Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.4.4.2. Key Country Dynamics
      • 7.4.4.3. Competitive Scenario
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.4.5.2. Key Country Dynamics
      • 7.4.5.3. Competitive Scenario
    • 7.4.6. Thailand
      • 7.4.6.1. Thailand Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Competitive Scenario
    • 7.4.7. Australia
      • 7.4.7.1. Australia Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.4.7.2. Key Country Dynamics
      • 7.4.7.3. Competitive Scenario
  • 7.5. Latin America
    • 7.5.1. Latin America Computational Biology Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.5.2.2. Key Country Dynamics
      • 7.5.2.3. Competitive Scenario
    • 7.5.3. Mexico
      • 7.5.3.1. Mexico Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.5.3.2. Key Country Dynamics
      • 7.5.3.3. Competitive Scenario
    • 7.5.4. Argentina
      • 7.5.4.1. Argentina Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.5.4.2. Key Country Dynamics
      • 7.5.4.3. Competitive Scenario
  • 7.6. MEA
    • 7.6.1. MEA Computational Biology Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.6.2.2. Key Country Dynamics
      • 7.6.2.3. Competitive Scenario
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.6.3.2. Key Country Dynamics
      • 7.6.3.3. Competitive Scenario
    • 7.6.4. UAE
      • 7.6.4.1. UAE Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.6.4.2. Key Country Dynamics
      • 7.6.4.3. Competitive Scenario
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.6.5.2. Key Country Dynamics
      • 7.6.5.3. Competitive Scenario

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share/Position Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. DNAnexus, Inc.
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Illumina, Inc.
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Thermo Fisher Scientific, Inc.
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Schrodinger, Inc.
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Compugen
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Aganitha AI Inc.
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Genedata AG
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. QIAGEN
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. SIMULATIONS PLUS
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Fios Genomics
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America computational biology market, by country, 2018 - 2030 (USD million)
  • Table 4 North America computational biology market, by service, 2018 - 2030 (USD million)
  • Table 5 North America computational biology market, by application, 2018 - 2030 (USD million)
  • Table 6 North America computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 7 U.S. computational biology market, by service, 2018 - 2030 (USD million)
  • Table 8 U.S computational biology market, by application, 2018 - 2030 (USD million)
  • Table 9 U.S computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 10 Canada computational biology market, by service, 2018 - 2030 (USD million)
  • Table 11 Canada computational biology market, by application, 2018 - 2030 (USD million)
  • Table 12 Canada computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 13 Europe computational biology market, by country, 2018 - 2030 (USD million)
  • Table 14 Europe computational biology market, by service, 2018 - 2030 (USD million)
  • Table 15 Europe computational biology market, by application, 2018 - 2030 (USD million)
  • Table 16 Europe computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 17 UK computational biology market, by service, 2018 - 2030 (USD million)
  • Table 18 UK computational biology market, by application, 2018 - 2030 (USD million)
  • Table 19 UK computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 20 Germany computational biology market, by service, 2018 - 2030 (USD million)
  • Table 21 Germany computational biology market, by application, 2018 - 2030 (USD million)
  • Table 22 Germany computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 23 France computational biology market, by service, 2018 - 2030 (USD million)
  • Table 24 France computational biology market, by application, 2018 - 2030 (USD million)
  • Table 25 France computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 26 Italy computational biology market, by service, 2018 - 2030 (USD million)
  • Table 27 Italy computational biology market, by application, 2018 - 2030 (USD million)
  • Table 28 Italy computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 29 Spain computational biology market, by service, 2018 - 2030 (USD million)
  • Table 30 Spain computational biology market, by application, 2018 - 2030 (USD million)
  • Table 31 Spain computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 32 Denmark computational biology market, by service, 2018 - 2030 (USD million)
  • Table 33 Denmark computational biology market, by application, 2018 - 2030 (USD million)
  • Table 34 Denmark computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 35 Sweden computational biology market, by service, 2018 - 2030 (USD million)
  • Table 36 Sweden computational biology market, by application, 2018 - 2030 (USD million)
  • Table 37 Sweden computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 38 Norway computational biology market, by service, 2018 - 2030 (USD million)
  • Table 39 Norway computational biology market, by application, 2018 - 2030 (USD million)
  • Table 40 Norway computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 41 Asia Pacific computational biology market, by country, 2018 - 2030 (USD million)
  • Table 42 Asia Pacific computational biology market, by service, 2018 - 2030 (USD million)
  • Table 43 Asia Pacific computational biology market, by application, 2018 - 2030 (USD million)
  • Table 44 Asia Pacific computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 45 China computational biology market, by service, 2018 - 2030 (USD million)
  • Table 46 China computational biology market, by application, 2018 - 2030 (USD million)
  • Table 47 China computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 48 Japan computational biology market, by service, 2018 - 2030 (USD million)
  • Table 49 Japan computational biology market, by application, 2018 - 2030 (USD million)
  • Table 50 Japan computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 51 India computational biology market, by service, 2018 - 2030 (USD million)
  • Table 52 India computational biology market, by application, 2018 - 2030 (USD million)
  • Table 53 India computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 54 South Korea computational biology market, by service, 2018 - 2030 (USD million)
  • Table 55 South Korea computational biology market, by application, 2018 - 2030 (USD million)
  • Table 56 South Korea computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 57 Australia computational biology market, by service, 2018 - 2030 (USD million)
  • Table 58 Australia computational biology market, by application, 2018 - 2030 (USD million)
  • Table 59 Australia computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 60 Thailand computational biology market, by service, 2018 - 2030 (USD million)
  • Table 61 Thailand computational biology market, by application, 2018 - 2030 (USD million)
  • Table 62 Thailand computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 63 Latin America computational biology market, by country, 2018 - 2030 (USD million)
  • Table 64 Latin America computational biology market, by service, 2018 - 2030 (USD million)
  • Table 65 Latin America computational biology market, by application, 2018 - 2030 (USD million)
  • Table 66 Latin America computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 67 Brazil computational biology market, by service, 2018 - 2030 (USD million)
  • Table 68 Brazil computational biology market, by application, 2018 - 2030 (USD million)
  • Table 69 Brazil computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 70 Mexico computational biology market, by service, 2018 - 2030 (USD million)
  • Table 71 Mexico computational biology market, by application, 2018 - 2030 (USD million)
  • Table 72 Mexico computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 73 Argentina computational biology market, by service, 2018 - 2030 (USD million)
  • Table 74 Argentina computational biology market, by application, 2018 - 2030 (USD million)
  • Table 75 Argentina computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 76 Middle East & Africa computational biology market, by country, 2018 - 2030 (USD million)
  • Table 77 Middle East & Africa computational biology market, by service, 2018 - 2030 (USD million)
  • Table 78 Middle East & Africa computational biology market, by application, 2018 - 2030 (USD million)
  • Table 79 Middle East & Africa computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 80 South Africa computational biology market, by service, 2018 - 2030 (USD million)
  • Table 81 South Africa computational biology market, by application, 2018 - 2030 (USD million)
  • Table 82 South Africa computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 83 Saudi Arabia computational biology market, by service, 2018 - 2030 (USD million)
  • Table 84 Saudi Arabia computational biology market, by application, 2018 - 2030 (USD million)
  • Table 85 Saudi Arabia computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 86 UAE computational biology market, by service, 2018 - 2030 (USD million)
  • Table 87 UAE computational biology market, by application, 2018 - 2030 (USD million)
  • Table 88 UAE computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 89 Kuwait computational biology market, by service, 2018 - 2030 (USD million)
  • Table 90 Kuwait computational biology market, by application, 2018 - 2030 (USD million)
  • Table 91 Kuwait computational biology market, by end-use, 2018 - 2030 (USD million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market Segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global computational biology market- Key market driver analysis
  • Fig. 7 Global computational biology market - Key market restraint analysis
  • Fig. 8 Global computational biology market - Porter's analysis
  • Fig. 9 Global computational biology market - PESTEL analysis
  • Fig. 10 Global computational biology market: Service outlook key takeaways
  • Fig. 11 Global computational biology market: Service movement analysis
  • Fig. 12 Databases market estimates, 2018 - 2030 (USD Million)
  • Fig. 13 Infrastructure & hardware market estimates, 2018 - 2030 (USD Million)
  • Fig. 14 Software platform market estimates, 2018 - 2030 (USD Million)
  • Fig. 15 Global computational biology market: Application outlook key takeaways
  • Fig. 16 Global computational biology market: Application movement analysis
  • Fig. 17 Drug discovery & disease modeling market estimates, 2018 - 2030 (USD Million)
  • Fig. 18 Target identification market estimates, 2018 - 2030 (USD Million)
  • Fig. 19 Target validation market estimates, 2018 - 2030 (USD Million)
  • Fig. 20 Lead discovery market estimates, 2018 - 2030 (USD Million)
  • Fig. 21 Lead optimization market estimates, 2018 - 2030 (USD Million)
  • Fig. 22 Preclinical drug development market estimates, 2018 - 2030 (USD Million)
  • Fig. 23 Pharmacokinetics market estimates, 2018 - 2030 (USD Million)
  • Fig. 24 Pharmacodynamics market estimates, 2018 - 2030 (USD Million)
  • Fig. 25 Clinical trials market estimates, 2018 - 2030 (USD Million)
  • Fig. 26 Phase I market estimates, 2018 - 2030 (USD Million)
  • Fig. 27 Phase II market estimates, 2018 - 2030 (USD Million)
  • Fig. 28 Phase III market estimates, 2018 - 2030 (USD Million)
  • Fig. 29 Phase IV market estimates, 2018 - 2030 (USD Million)
  • Fig. 30 Computational genomics market estimates, 2018 - 2030 (USD Million)
  • Fig. 31 Computational proteomics market estimates, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 33 Global computational biology market: End-use outlook key takeaways
  • Fig. 34 Global computational biology market: End-use movement analysis
  • Fig. 35 Academic & research market estimates, 2018 - 2030 (USD Million)
  • Fig. 36 Industrial market estimates, 2018 - 2030 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 Global computational biology market: Regional movement analysis
  • Fig. 39 North America computational biology market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. computational biology market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada computational biology market, 2018 - 2030 (USD Million)
  • Fig. 42 Europe computational biology market, 2018 - 2030 (USD Million)
  • Fig. 43 UK computational biology market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany computational biology market, 2018 - 2030 (USD Million)
  • Fig. 45 France computational biology market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain computational biology market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy computational biology market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark computational biology market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden computational biology market, 2018 - 2030 (USD Million)
  • Fig. 50 Norway computational biology market, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific computational biology market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan computational biology market, 2018 - 2030 (USD Million)
  • Fig. 53 China computational biology market, 2018 - 2030 (USD Million)
  • Fig. 54 India computational biology market, 2018 - 2030 (USD Million)
  • Fig. 55 South Korea computational biology market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia computational biology market, 2018 - 2030 (USD Million)
  • Fig. 57 Thailand computational biology market, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America computational biology market, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil computational biology market, 2018 - 2030 (USD Million)
  • Fig. 60 Mexico computational biology market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina computational biology market, 2018 - 2030 (USD Million)
  • Fig. 62 MEA computational biology market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa computational biology market, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia computational biology market, 2018 - 2030 (USD Million)
  • Fig. 65 UAE computational biology market, 2018 - 2030 (USD Million)
  • Fig. 66 Kuwait computational biology market, 2018 - 2030 (USD Million)
  • Fig. 67 Strategy framework